Kevin P. Raisch

Kevin P. Raisch

Auto-generated profile, based on publicly available information

Kevin P. Raisch

Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2007 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ASAhmad Safavy
Ahmad Safavy
KRKevin P. Raisch
Kevin P. Raisch
SMSushma Mantena
Sushma Mantena
LSLeisa L. Sanford
Leisa L. Sanford
SSSimon W. Sham
Simon W. Sham
JBJames A. Bonner
James A. Bonner

1 December 1999 in Cancer Biotherapy and Radiopharmaceuticals
Verified
Journal Article
Closed access
MSMansoor N. Saleh
Mansoor N. Saleh
KRKevin P. Raisch
Kevin P. Raisch
MSMurray A. Stackhouse
Murray A. Stackhouse
WGWilliam E. Grizzle
William E. Grizzle
JBJames A. Bonner
James A. Bonner
DBDonald J. Buchsbaum
Donald J. Buchsbaum
Background Monoclonal antibodies (mAb) to epidermal growth factor receptor (EGFr) inhibit tumor cell proliferation and enhance cytotoxicity of chemotherapeutic agents. The purpose of this study was to investigate the interaction of the anti-EGFr antibody C225 combined with radiotherapy (RT) on EGFr expressing A431 human epidermoid cancer cells. Methods Cell proliferation, apoptosis, EGFr expression and phosphorylation, and clonogenic survival were assayed in vitro. A431 tumor growth inhibition and immunohistochemistry analysis of EGFr expression and apoptosis were assessed in vivo. Results C225 plus RT produced greater inhibition of A431 cell proliferation than C225 or RT alone which was corroborated by enhanced apoptosis. Similar clonogenic survival occurred following the addition of C225 to RT, although colonies were smaller in the presence of C225. C225 produced inhibition of EGF-induced phosphorylation of EGFr without concurrent down-regulation of surface receptor, which was not altered by RT. Combine...

1 November 2002 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
DBDonald J. Buchsbaum
Donald J. Buchsbaum
JBJames A Bonner
James A Bonner
WGWilliam E Grizzle
William E Grizzle
MSMurray A Stackhouse
Murray A Stackhouse
MCMark Carpenter
Mark Carpenter
KRKevin P Raisch
Kevin P Raisch

1 November 1999 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ASAhmad Safavy
Ahmad Safavy
KRKevin P. Raisch
Kevin P. Raisch
MKM. B. Khazaeli
M. B. Khazaeli
DBDonald J. Buchsbaum
Donald J. Buchsbaum
JBJames A. Bonner
James A. Bonner

28 January 2003 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
ASAhmad Safavy
Ahmad Safavy
JBJames A. Bonner
James A. Bonner
HWHarlan W. Waksal
Harlan W. Waksal
DBDonald J. Buchsbaum
Donald J. Buchsbaum
GGG. Yancey Gillespie
G. Yancey Gillespie
KRKevin P. Raisch
Kevin P. Raisch

1 September 2009 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
JBJames A. Bonner
James A. Bonner
HTHoa Q. Trummell
Hoa Q. Trummell
CWChristopher Douglas Willey
Christopher Douglas Willey
BPBrian A. Plants
Brian A. Plants
KRKevin P. Raisch
Kevin P. Raisch